QS Investors’s Globus Medical GMED Stock Holding History

QS Investors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$776K	Hold	10,000	–	–	0.01%	568
2021 Q1	$617K	Hold	10,000	–	–	0.01%	711
2020 Q4	$652K	Hold	10,000	–	–	0.01%	658
2020 Q3	$496K	Sell	10,000 -32,900	-77%	-$1.7M	0.01%	693
2020 Q2	$2.05M	Hold	42,900	–	–	0.03%	478
2020 Q1	$1.82M	Hold	42,900	–	–	0.03%	448
2019 Q4	$2.55M	Sell	42,900 -600	-1%	-$32.6K	0.03%	510
2019 Q3	$2.22M	Hold	43,500	–	–	0.02%	531
2019 Q2	$1.84M	Sell	43,500 -751	-2%	-$32.6K	0.02%	612
2019 Q1	$2.19M	Sell	44,251 -264	-0.6%	-$11.9K	0.02%	566
2018 Q4	$1.93M	Hold	44,515	–	–	0.02%	562
2018 Q3	$2.53M	Buy	44,515 +42,900	+2,656%	+$2.26M	0.02%	545
2018 Q2	$81K	Hold	1,615	–	–	﹤0.01%	1449
2018 Q1	$80K	Hold	1,615	–	–	﹤0.01%	1412
2017 Q4	$66K	Hold	1,615	–	–	﹤0.01%	1438
2017 Q3	$48K	Hold	1,615	–	–	﹤0.01%	1530
2017 Q2	$54K	Hold	1,615	–	–	﹤0.01%	1496
2017 Q1	$48K	Buy	1,615 +1,600	+10,667%	+$43.7K	﹤0.01%	1535
2016 Q4	$1K	Hold	15	–	–	﹤0.01%	1610
2016 Q3	$1K	Buy	15 +4	+36%	+$94	﹤0.01%	1593
2016 Q2	$1K	Buy	+11	New	+$264	﹤0.01%	1628
2016 Q1	–	Sell	-11	Closed	-$1K	–	2011
2015 Q4	$1K	Buy	+11	New	+$276	﹤0.01%	1648

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

QS Investors's GMED Position: Q2 2021 in Review

QS Investors held its Globus Medical (GMED) position steady in Q2 2021 at 10,000 shares worth $776K. The position accounts for 0.01% of the portfolio, ranked #568.

QS Investors first reported a position in GMED in Q4 2015 and has held it in 22 quarters since. The position peaked at $2.55M in Q4 2019. 354 funds tracked by Wall St. Rank hold GMED as of Q2 2021.

QS Investors held 10,000 shares of Globus Medical worth $776K as of Q2 2021.
QS Investors left its Globus Medical share count unchanged in Q2 2021.
Globus Medical made up 0.01% of QS Investors's portfolio in Q2 2021, its #568 holding.
QS Investors first reported a position in Globus Medical in Q4 2015 and has held it in 22 quarters since.
QS Investors's Globus Medical position peaked at $2.55M in Q4 2019.
354 funds tracked by Wall St. Rank held Globus Medical as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.